Exploration of the P-3 region of PEXEL peptidomimetics leads to a potent inhibitor of the Plasmodium protease, plasmepsin V
Michelle Gazdik, Kate E Jarman, Matthew T O'Neill, Anthony N Hodder, Kym N Lowes, Helene Jousset Sabroux, Alan F Cowman, Justin A Boddey, Brad E Sleebs
Bioorganic & Medicinal Chemistry | PERGAMON-ELSEVIER SCIENCE LTD | Published : 2016
Awarded by National Health and Medical Research Council of Australia
This work was funded by the National Health and Medical Research Council of Australia ( Project Grant 1010326 to J. A. B., Program Grant 1092789 to A. F. C.), the Australian Cancer Research Foundation, the Victorian State Government Operational Infrastructure Support and Australian Government NHMRC IRIISS. We thank the University of Melbourne for the provision of an Australian Postgraduate Award to M. G. A. F. C. is a Howard Hughes International Scholar and an Australia Fellow of the NHMRC. J. A. B. is an Australian Research Council QEII Fellow.